Article Information
History
- May 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- George Nicholson1,9,*,#,
- Brieuc Lehmann1,9,*,
- Tullia Padellini2,9,
- Koen B Pouwels3,4,
- Radka Jersakova5,9,
- James Lomax5,9,
- Ruairidh E King6,9,
- Ann-Marie Mallon6,9,
- Peter J Diggle7,9,
- Sylvia Richardson8,9,
- Marta Blangiardo2,9 and
- Chris Holmes1,5,6,9
- 1University of Oxford, UK
- 2MRC Centre for Environment and Health, Dept of Epidemiology and Biostatistics, Imperial College London
- 3Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, UK
- 4The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, University of Oxford, Oxford, UK
- 5The Alan Turing Institute, London, UK
- 6MRC Harwell Institute, Harwell, UK
- 7CHICAS, Lancaster Medical School, Lancaster University, UK
- 8MRC Biostatistics Unit, University of Cambridge, UK
- 9Joint Biosecurity Centre, Turing and Royal Statistical Society Laboratory
- ↵#Corresponding author; email: george.nicholson{at}stats.ox.ac.uk
↵* These authors contributed equally to this research.
Posted May 18, 2021.
Local prevalence of transmissible SARS-CoV-2 infection: an integrative causal model for debiasing fine-scale targeted testing data
